Stock AEGR AEGERION PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Aegerion Pharmaceuticals, Inc.

Equities

AEGR

US00767E1029

Delayed Nasdaq
Other stock markets
 04:00:00 2016-11-29 pm EST 		5-day change 1st Jan Change
1.97 USD +5.35% Intraday chart for Aegerion Pharmaceuticals, Inc. +4.23% -80.50%
2015 AbbVie : Venture capitalists ride biotech wave one drug at a time RE
2015 Aegerion Pharmaceuticals : Exclusive: Top investors push Aegerion to oust CEO, consider sale - sources RE

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Aegerion Pharmaceuticals, Inc. and QLT Inc. Complete Merger Transaction; QLT to Change Name to Novelion Therapeutics Inc.
GL
Aegerion Pharmaceuticals’ JUXTAPID® (lomitapide) Capsules for the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) Receives Pricing Authorization in Japan
GL
Aegerion Pharmaceuticals Announces Third Quarter 2016 Financial Results
GL
Aegerion Pharmaceuticals : Research Reports Coverage on Biotech Stocks -- Merrimack Pharma, Aurinia Pharma, Aegerion Pharma, and TG Therapeutics
PR
Aegerion Pharmaceuticals' : JUXTAPID® (lomitapide) Capsules Approved in Japan for the Treatment of Homozygous Familial Hypercholesterolemia (HoFH)
PU
Aegerion Pharmaceuticals’ JUXTAPID® (lomitapide) Capsules Approved in Japan for the Treatment of Homozygous Familial Hypercholesterolemia (HoFH)
GL
Aegerion Pharmaceuticals Observes Familial Hypercholesterolemia Awareness Day
GL
Aegerion Pharmaceuticals Appoints Remi Menes as Chief Commercial Officer
GL
Aegerion Pharmaceuticals Announces Second Quarter 2016 Financial Results
GL
Aegerion Pharmaceuticals Announces Cost Reduction Plans
GL
Aegerion Pharmaceuticals and QLT Inc. Agree to Strategic Merger
GL
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
GL
Aegerion Pharmaceuticals Announces First Quarter 2016 Financial Results
GL
Aegerion Pharmaceuticals Announces Preliminary Agreements in Principle With DOJ and SEC Related to Ongoing Investigations
GL
Aegerion Pharmaceuticals to Announce First Quarter 2016 Financial Results on Monday, May 16
GL
Aegerion Pharmaceuticals : Grants Stock Options Under Inducement Program
PU
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
GL
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
GL
Aegerion Pharmaceuticals : Observes World Lipodystrophy Day
GL
Aegerion Pharmaceuticals : Grants Stock Options Under Inducement Program
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AEGR Stock
  4. News Aegerion Pharmaceuticals, Inc.